Ivax ethnic H&BA, derm business likely spin-off from merger with Bergen Brunswig.
This article was originally published in The Rose Sheet
Executive Summary
IVAX POSSIBLE SPIN-OFF OF ETHNIC H&BA, DERM PRODUCTS appears likely in light of Bergen Brunswig's professed focus on Ivax' generic prescription drug business and proprietary pharmaceuticals pipeline following the proposed merger of the two companies announced Nov. 11. Miami, Fla.-based Ivax in the past has identified its ethnic H&BA business as a potential spin-off candidate. Sales for the ethnic and dermatologicals businesses in 1995 were roughly $63 mil.